Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2017 / Jul / Some Live, Some Die
Retina Research & Innovations Neuro-ophthalmology

Some Live, Some Die

Sox11 – the transcription factor that is decidedly double-edged in optic nerve regeneration

By Ruth Steer 7/11/2017 1 min read

Share

GFP-expressing RGCs on a flat-mounted retina showing the axons leading to the optic nerve head. Credit: Fengfeng Bei.

Regenerating, regrowing or replacing diseased tissues is a hot topic. And one area under particular scrutiny is neural regeneration; it is known that the peripheral nervous system can intrinsically repair itself, but the central nervous system (CNS) essentially lacks this ability. Now, recent studies on the optic nerve could bring CNS regeneration one step closer…

“Clinically, we aim to develop regenerative medicine for optic nerve injury, such as from glaucoma,” says Fengfeng Bei, of Zhigang He’s laboratory at Harvard Medical School, Boston, USA, and corresponding author on the recently published paper (1). “Scientifically, we reason that studying optic nerve regeneration may reveal more general insight into tissue repair and regeneration for brain and spinal cord injuries.” In a bid to determine which factors influence rejuvenation and growth of adult retinal ganglion cells (RGCs) forming the optic nerve, the group overexpressed seven different transcription factors in murine retinae using adeno-associated virus (AAV2) vectors. They found that overexpression of Sox11 significantly increased regeneration of RGC axons following crush injury (p<0.001 compared with control). But they were surprised to find that the transcription factor had a killing effect on the α-RGC subtype in both intact retinas and those following optic nerve crush. “The ‘double-edged’ effect of Sox11 is intriguing; no previously known pro-regenerative treatments promote cell death,” says Bei. “It completely kills α-RGCs, which are a cell type we have previously shown to be relatively resilient and responsive to other regenerative approaches” (2). In their future work, the team hopes to chart all subtypes of RGC in terms of responses to injury and pro-regenerative interventions. For now, Bei concludes that they have learnt two major lessons: “First, it is feasible to rejuvenate injured adult neurons, and second, different subsets of cells – even among a seemingly homogenous population – may respond very differently to the same regenerative approach.”

References

  1. MW Norsworthy et al., “Sox11 expression promotes regeneration of some retinal ganglion cell types but kills others”, Neuron, 94, 1112–1120 (2017). PMID: 28641110. X Duan et al., “Subtype-specific regeneration of retinal ganglion cells following axotomy: effects of osteopontin and mTOR signaling”, Neuron, 85, 1244–1256 (2015). PMID: 25754821.

About the Author(s)

Ruth Steer

More Articles by Ruth Steer

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: